SCHEMBL9517017

SCHEMBL9517017

CC(C)(CNC(N)=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.50
KMT2A Q03164 1/20 0.50
TAAR1 Q96RJ0 1/20 0.48
CHRM2 P08172 1/20 0.47
CHRM1 P11229 1/20 0.47
CHRM3 P20309 1/20 0.47
CYP2C19 P33261 1/20 0.44
HIF1A Q16665 1/20 0.44
LMNA P02545 1/20 0.43
BCAT2 O15382 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3112777 0.85 CYP2C19 (0.47) MAPTKMT2ATAAR1CYP2C19HIF1A
SCHEMBL8499984 0.83 ACACB (0.51) TAAR1CHRM2CHRM1CHRM3CYP2C19
SCHEMBL4231538 0.82 BCAT2 (0.47) MAPTKMT2ACHRM2CHRM1CHRM3
SCHEMBL11491536 0.81 TAAR1 (0.48) MAPTKMT2ATAAR1CYP2C19LMNA
SCHEMBL8499982 0.81 CYP2C19 (0.44) MAPTKMT2ATAAR1CYP2C19HIF1A
SCHEMBL20909439 0.81 BCAT2 (0.46) MAPTKMT2ACHRM2CHRM1CHRM3
SCHEMBL17662698 0.80 KCNN4 (0.47) TAAR1CYP2C19HIF1AHDAC3HDAC4
SCHEMBL2332445 0.80 PRSS1 (0.61) LMNA
SCHEMBL10843770 0.80 ALDH1A1 (0.50) MAPTKMT2ALMNA
SCHEMBL3901654 0.79 LMNA (0.48) MAPTKMT2ACHRM2CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0344425-B1 N-[[(2,6-disubstituted)phenyl]-N'- arylalkyl] ureas as antihypercholesterolemic and antiatherosclerotic agents WARNER LAMBERT CO (US) 1993-12-08 EP claimed
EP-0344425-A2 N-[[(2,6-disubstituted)phenyl]-N'- arylalkyl] ureas as antihypercholesterolemic and antiatherosclerotic agents WARNER-LAMBERT COMPANY (US) 1989-12-06 EP claimed
CN-109641857-A Phenyl Urea Derivatives as N- formyl peptide receptor regulator 阿勒根公司 2019-04-16 CN disclosed
EP-0344425-B1 N-[[(2,6-disubstituted)phenyl]-N'- arylalkyl] ureas as antihypercholesterolemic and antiatherosclerotic agents WARNER LAMBERT CO (US) 1993-12-08 EP disclosed
EP-0344425-A2 N-[[(2,6-disubstituted)phenyl]-N'- arylalkyl] ureas as antihypercholesterolemic and antiatherosclerotic agents WARNER-LAMBERT COMPANY (US) 1989-12-06 EP disclosed